Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 1.38% is 48% below its 1-year average of 2.66%, around the middle of its 1-year range (-2.79%–6.15%).
2.75% below its 12-month average of 1.42%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 1.66%.
OPERATING MARGIN
1.38%
OPERATING MARGIN AVG TTM
1.42%
OPERATING MARGIN AVG 3Y
N/A
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-2.75%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 744 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Lumexa Imaging Holdings, Inc. Common Stock
Market Cap
$1.02B
Operating Margin
1.38%
TTM Avg
1.42%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.00B
Operating Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.04B
Operating Margin
4.18%
TTM Avg
2.97%
3Y Avg
7.13%
5Y Avg
8.72%
Market Cap
$997.66M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.04B
Operating Margin
-8.99%
TTM Avg
-4.92%
3Y Avg
-23.48%
5Y Avg
-24.49%
Market Cap
$1.04B
Operating Margin
-377.11%
TTM Avg
-200.94%
3Y Avg
-143.24%
5Y Avg
-174.04%
Market Cap
$991.32M
Operating Margin
-130.20%
TTM Avg
-311.82%
3Y Avg
-583.08%
5Y Avg
-487.88%
Market Cap
$1.04B
Operating Margin
-1576.67%
TTM Avg
-1255.13%
3Y Avg
-1048.04%
5Y Avg
-849.59%
Market Cap
$988.11M
Operating Margin
-33.86%
TTM Avg
-38.38%
3Y Avg
-66.13%
5Y Avg
-173.51%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI) | $1.02B | 1.38% | 1.42% | N/A | N/A |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $1.00B | N/A | N/A | N/A | N/A |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.04B | 4.18% | 2.97% | 7.13% | 8.72% |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $997.66M | 0.00% | 0.00% | 0.00% | 0.00% |
| Castle Biosciences, Inc. (CSTL)vs › | $1.04B | -8.99% | -4.92% | -23.48% | -24.49% |
| Immatics N.V. (IMTX)vs › | $1.04B | -377.11% | -200.94% | -143.24% | -174.04% |
| MeiraGTx Holdings plc (MGTX)vs › | $991.32M | -130.20% | -311.82% | -583.08% | -487.88% |
| Janux Therapeutics, Inc. (JANX)vs › | $1.04B | -1576.67% | -1255.13% | -1048.04% | -849.59% |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $988.11M | -33.86% | -38.38% | -66.13% | -173.51% |
| Aktis Oncology, Inc. (AKTS)vs › | $986.83M | -1149.52% | -2324.93% | -1162.47% | -1162.47% |
Gross Margin
11.8%
Operating Margin
1.4%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 1.66% |
| 2026-03-31 | 1.79% |
| 2025-12-31 | -2.79% |
| 2025-09-30 | 5.01% |
| 2025-03-31 | 4.11% |
| 2024-12-31 | 6.15% |
